Impact of Latent Tuberculosis on Diabetes.

heterologous immunity inflammatory diseases innate immunity latent tuberculosis low-grade inflammation type-2 diabetes mellitus

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
15 06 2022
Historique:
received: 04 11 2021
accepted: 14 02 2022
pubmed: 17 2 2022
medline: 18 6 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

While an increased risk of active and latent tuberculosis infection (LTBI) in people with type-2 diabetes (DM) has been demonstrated, it is less well characterized whether LTBI is associated with an increased risk of developing DM. We investigated the link between LTBI and DM in people living with HIV in the Swiss HIV Cohort Study via time-dependent Cox proportional hazards models. We found that LTBI significantly increased the risk of developing DM (HR = 1.47), which was robust across different adjustment and censoring techniques. Our results thus suggest that LTBI may be associated with an increased risk of developing DM.

Identifiants

pubmed: 35172332
pii: 6529706
doi: 10.1093/infdis/jiac054
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2229-2234

Subventions

Organisme : Swiss National Science Foundation
ID : 177499
Pays : Switzerland

Investigateurs

I Abela (I)
K Aebi-Popp (K)
A Anagnostopoulos (A)
M Battegay (M)
E Bernasconi (E)
D L Braun (DL)
H C Bucher (HC)
A Calmy (A)
M Cavassini (M)
A Ciuffi (A)
G Dollenmaier (G)
M Egger (M)
L Elzi (L)
J Fehr (J)
J Fellay (J)
H Furrer (H)
C A Fux (CA)
H F Günthard (HF)
A Hachfeld (A)
D Haerry (D)
B Hasse (B)
H H Hirsch (HH)
M Hoffmann (M)
I Hösli (I)
M Huber (M)
C R Kahlert (CR)
L Kaiser (L)
O Keiser (O)
T Klimkait (T)
R D Kouyos (RD)
H Kovari (H)
K Kusejko (K)
G Martinetti (G)
B Martinez de Tejada (B)
C Marzolini (C)
K J Metzner (KJ)
N Müller (N)
J Nemeth (J)
D Nicca (D)
P Paioni (P)
G Pantaleo (G)
M Perreau (M)
A Rauch (A)
P Schmid (P)
R Speck (R)
M Stöckle (M)
P Tarr (P)
A Trkola (A)
G Wandeler (G)
S Yerly (S)

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Burcu Tepekule (B)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Katharina Kusejko (K)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Marius Zeeb (M)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Philip E Tarr (PE)

Department of Medicine and Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital Baselland, University of Basel, Bruderholz, Switzerland.

Alexandra Calmy (A)

Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland.

Manuel Battegay (M)

Division of Infectious Diseases and Hospital Hygiene, University Hospital Basel, University of Basel, Basel, Switzerland.

Hansjakob Furrer (H)

Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Matthias Cavassini (M)

Division of Infectious Diseases, University Hospital, Lausanne, Switzerland.

Enos Bernasconi (E)

Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.

Julia Notter (J)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Huldrych F Günthard (HF)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Johannes Nemeth (J)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Roger D Kouyos (RD)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH